$322M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RLMD Relmada Therapeutics Inc | 7.3M | −13.3% | $51M | 15.8% |
| 2 | CCCC C4 Therapeutics Inc | 7.2M | +220.0% | $34M | 10.4% |
| 3 | COGT Cogent Biosciences Inc | 865,000 | +9.8% | $33M | 10.4% |
| 4 | KOD Kodiak Sciences Inc | 500,000 | +31.6% | $19M | 6.0% |
| 5 | RLAY Relay Therapeutics Inc | 970,000 | +44.2% | $18M | 5.6% |
| 6 | ZNTL Zentalis Pharmaceuticals Inc | 3.7M | +1.9% | $18M | 5.6% |
| 7 | EWTX Edgewise Therapeutics Inc | 290,000 | −17.1% | $12M | 3.7% |
| 8 | MAZE Maze Therapeutics Inc | 335,000 | +30.1% | $10M | 3.1% |
| 9 | IVA Inventiva Sa | 2.4M | +355.1% | $9M | 2.9% |
| 10 | ANL Adlai Nortye Ltd | 764,876 | −39.5% | $9M | 2.7% |
| 11 | ELVN Enliven Therapeutics Inc | 160,000 | — | $8M | 2.5% |
| 12 | PALI Palisade Bio Inc | 3.0M | +0.0% | $6M | 1.9% |
| 13 | IKT Inhibikase Therapeutics Inc | 3.0M | −14.3% | $6M | 1.9% |
| 14 | ADAG Adagene Inc | 1.2M | — | $5M | 1.6% |
| 15 | FORTE BIOSCIENCES INC Forte Biosciences Inc | 225,000 | — | $5M | 1.5% |
| 16 | INFLARX NV Inflarx Nv | 2.0M | — | $4M | 1.4% |
| 17 | ASMB Assembly Biosciences Inc | 160,000 | — | $4M | 1.4% |
| 18 | PMN Promis Neurosciences Inc | 324,977 | +0.0% | $4M | 1.3% |
| 19 | CTNM Contineum Therapeutics Inc | 260,000 | — | $4M | 1.3% |
| 20 | CMPS Compass Pathways Plc | 300,000 | — | $4M | 1.3% |
| 21 | DFTX Definium Therapeutics Inc | 85,000 | — | $4M | 1.2% |
| 22 | SLGL Sol-Gel Technologies Ltd | 52,000 | +67.7% | $4M | 1.2% |
| 23 | BIOA Bioage Labs Inc | 155,000 | — | $4M | 1.2% |
| 24 | SCYX Scynexis Inc | 756,884 | — | $3M | 1.0% |
| 25 | PROQR THRAPEUTICS N V Proqr Thrapeutics N V | 1.5M | — | $3M | 0.9% |
| 26 | RZLT Rezolute Inc | 403,410 | — | $2M | 0.7% |
| 27 | LPCN Lipocine Inc New | 810,000 | +80.0% | $2M | 0.6% |
| 28 | CUE Cue Biopharma Inc | 50,000 | — | $2M | 0.5% |
| 29 | CALC Calcimedica Inc | 1.2M | — | $1M | 0.4% |
| 30 | QUINCE THERAPEUTICS INC Quince Therapeutics Inc | 40,375 | — | $734,421 | 0.2% |
| 31 | KTTA Pasithea Therapeutics Corp | 1.0M | −52.4% | $515,400 | 0.2% |
| 32 | MTRI Inmed Pharmaceuticals Inc | 325,000 | — | $503,750 | 0.2% |
| 33 | NMRA Neumora Therapeutics Inc. | 100,000 | — | $170,000 | 0.1% |
| 34 | NXTC Nextcure Inc | 64,464 | −75.7% | $103,142 | 0.0% |